Phase 2 RCT | Efficacy of adjunctive D-Cycloserine to intermittent theta-burst stimulation for major depressive disorder.
19 Oct, 2022 | 14:16h | UTCEfficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder: A Randomized Clinical Trial – JAMA Psychiatry (link to abstract – $ for full-text)
Commentaries:
Commentary on Twitter
In this RCT w 50 participants, those receiving intermittent theta-burst stimulation w adjunctive D-Cycloserine had significantly greater improvements in depressive symptoms compared to stimulation w placebo. https://t.co/AnP93WnkdG #Research
— JAMA Psychiatry (@JAMAPsych) October 12, 2022